File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Organoid cultures for cancer modeling.

TitleOrganoid cultures for cancer modeling.
Authors
Keywordscancer
organoids
Issue Date6-Jul-2023
PublisherElsevier
Citation
Cell Stem Cell, 2023, v. 30, n. 7, p. 917-937 How to Cite?
AbstractOrganoids derived from adult stem cells (ASCs) and pluripotent stem cells (PSCs) are important preclinical models for studying cancer and developing therapies. Here, we review primary tissue-derived and PSC-derived cancer organoid models and detail how they have the potential to inform personalized medical approaches in different organ contexts and contribute to the understanding of early carcinogenic steps, cancer genomes, and biology. We also compare the differences between ASC- and PSC-based cancer organoid systems, discuss their limitations, and highlight recent improvements to organoid culture approaches that have helped to make them an even better representation of human tumors.
Persistent Identifierhttp://hdl.handle.net/10722/331403
ISSN
2021 Impact Factor: 25.269
2020 SCImago Journal Rankings: 8.860

 

DC FieldValueLanguage
dc.contributor.authorYan, HHN-
dc.contributor.authorChan, AS-
dc.contributor.authorLai, FP-
dc.contributor.authorLeung, SY-
dc.date.accessioned2023-09-21T06:55:24Z-
dc.date.available2023-09-21T06:55:24Z-
dc.date.issued2023-07-06-
dc.identifier.citationCell Stem Cell, 2023, v. 30, n. 7, p. 917-937-
dc.identifier.issn1934-5909-
dc.identifier.urihttp://hdl.handle.net/10722/331403-
dc.description.abstractOrganoids derived from adult stem cells (ASCs) and pluripotent stem cells (PSCs) are important preclinical models for studying cancer and developing therapies. Here, we review primary tissue-derived and PSC-derived cancer organoid models and detail how they have the potential to inform personalized medical approaches in different organ contexts and contribute to the understanding of early carcinogenic steps, cancer genomes, and biology. We also compare the differences between ASC- and PSC-based cancer organoid systems, discuss their limitations, and highlight recent improvements to organoid culture approaches that have helped to make them an even better representation of human tumors.-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofCell Stem Cell-
dc.subjectcancer-
dc.subjectorganoids-
dc.titleOrganoid cultures for cancer modeling.-
dc.typeArticle-
dc.identifier.doi10.1016/j.stem.2023.05.012-
dc.identifier.pmid37315564-
dc.identifier.scopuseid_2-s2.0-85163852558-
dc.identifier.volume30-
dc.identifier.issue7-
dc.identifier.spage917-
dc.identifier.epage937-
dc.identifier.eissn1875-9777-
dc.identifier.issnl1875-9777-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats